Joshua Edwards Professor, Pathology and Laboratory Medicine, Indiana University School of Medicine
Pathology
Dr. Sunil Badve, MD
|
|
Give Review
Sunil Badve practices Pathology. He went to Albert Einstein College of Medicine. He received awards:"Regional Top Doctor". Sunil Badve is a published doctor and has 38 publications published. The lastest was: 'A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.
- Micronodular thymic neoplasms: case series and literature review with emphasis on the spectrum of differentiation.
- Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working ...
- Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.
- DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
- NUT midline carcinomas in the thymic region.
- ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting.
- NUT Midline Carcinoma Masquerading As a Thymic Carcinoma.
- The Association between Peritoneal Dialysis Modality and Peritonitis.
- Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
- Multiplexed protein analysis.
- The Utility of Immunostaining for NUT, GAGE7, and NY-ESO-1 in the Diagnosis of Spermatocytic Seminoma.
- The prognostic value of architectural patterns in a study of 37 type AB thymomas.
- Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.
- FOXP3 expression and nodal metastasis of breast cancer.
- Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity.
- ANTXR1, a stem cell enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
- EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor α
- A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
- The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases.
- NUT protein is not expressed in undifferentiated (anaplastic) thyroid carcinoma.
- Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bev...
- Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse.
- Role of AKT isotypes in breast cancer.
- Establishment and characterization of a novel cell line derived from human thymoma AB tumor.
- Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models.
- Molecular profiling assays in breast cancer: are we ready for prime time?
- Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy.
- Thymic Carcinoma: Outcomes After Surgical Resection.
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
- Differential gene expression profiling of esophageal adenocarcinoma.
- Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.
- NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
- Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers.
- Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer.
- Opportunistic infections in a patient with HIV and thymoma.
- A gene signature to determine metastatic behavior in thymomas.
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Albert Einstein College of Medicine -
Grant Medical College
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699732453 |
| Last Name Of The Provider | BADVE |
| First Name Of The Provider | SUNIL |
| View All |
Similar Doctors
|
|
Dr. Joseph K. Dowden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anise T. Burki, MD |
|
|
Dr. Kenneth Ryder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric A. Albright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond Konger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Konrad, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Xiaoyan Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Woodbridge, MD
This Doctor is OpenDoctor Recommended.
|